Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Akoya Biosciences, Inc. AKYA

Full chart Compare
Set alert

Price alert · AKYA

All alert types
1.29 0.00 (+0.00%)

At closeJul 8, 2025, 4:00 PM EDT

1.29 Day range 1.29
0.93 52-week range 3.42

Financial health

Altman Z-Score

-4.24 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.0×
FY 2019: -50.0×FY 2020: -44.4×FY 2021: -12.9×FY 2022: -5.1×FY 2023: -3.4×FY 2024: -2.0×
FY 2019 5y median -5.1× FY 2024
P/S 1.4×
FY 2019: 17.6×FY 2020: 17.5×FY 2021: 10.4×FY 2022: 4.8×FY 2023: 2.2×FY 2024: 1.4×
FY 2019 5y median 4.8× FY 2024
P/B 14.9×
FY 2019: -24.6×FY 2020: 41.0×FY 2021: 4.7×FY 2022: 6.2×FY 2023: 4.0×FY 2024: 14.9×
FY 2019 5y median 6.2× FY 2024
P/FCF -2.4×
FY 2019: -44.6×FY 2020: -73.2×FY 2021: -13.9×FY 2022: -5.9×FY 2023: -4.0×FY 2024: -2.4×
FY 2019 5y median -5.9× FY 2024
EV/EBITDA -5.0×
FY 2019: -78.5×FY 2020: -75.1×FY 2021: -14.0×FY 2022: -6.2×FY 2023: -4.8×FY 2024: -5.0×
FY 2019 5y median -6.2× FY 2024
EV/Sales 2.3×
FY 2019: 17.9×FY 2020: 17.9×FY 2021: 9.0×FY 2022: 4.8×FY 2023: 2.3×FY 2024: 2.3×
FY 2019 5y median 4.8× FY 2024
FCF Yield -41.1%
FY 2019: -2.2%FY 2020: -1.4%FY 2021: -7.2%FY 2022: -16.8%FY 2023: -25.2%FY 2024: -41.1%
FY 2019 5y median -16.8% FY 2024

Profitability

Gross Margin 58.6%
FY 2019: 58.4%FY 2020: 61.0%FY 2021: 62.3%FY 2022: 58.0%FY 2023: 58.3%FY 2024: 58.6%
FY 2019 5y median 58.6% FY 2024
Operating Margin -57.2%
FY 2019: -32.0%FY 2020: -27.1%FY 2021: -67.8%FY 2022: -88.4%FY 2023: -59.7%FY 2024: -57.2%
FY 2019 5y median -59.7% FY 2024
Net Margin -67.8%
FY 2019: -34.9%FY 2020: -39.4%FY 2021: -78.2%FY 2022: -94.4%FY 2023: -65.5%FY 2024: -67.8%
FY 2019 5y median -67.8% FY 2024
ROE -729.0%
FY 2019: 48.9%FY 2020: -92.4%FY 2021: -35.4%FY 2022: -120.6%FY 2023: -117.8%FY 2024: -729.0%
FY 2019 5y median -117.8% FY 2024
ROIC -47.3%
FY 2019: -19.8%FY 2020: -18.6%FY 2021: -22.7%FY 2022: -46.4%FY 2023: -38.8%FY 2024: -47.3%
FY 2019 5y median -38.8% FY 2024
ROA -44.3%
FY 2019: -16.5%FY 2020: -21.5%FY 2021: -22.5%FY 2022: -40.1%FY 2023: -35.1%FY 2024: -44.3%
FY 2019 5y median -35.1% FY 2024

Growth (YoY)

Revenue -15.5%
FY 2019: 0.0%FY 2020: 0.5%FY 2021: 29.4%FY 2022: 36.3%FY 2023: 29.1%FY 2024: -15.5%
FY 2019 FY 2024
Operating Income 19.0%
FY 2019: 0.0%FY 2020: 14.9%FY 2021: -223.9%FY 2022: -77.9%FY 2023: 12.9%FY 2024: 19.0%
FY 2019 FY 2024
EPS (diluted) 21.7%
FY 2019: 0.0%FY 2020: -12.5%FY 2021: -164.4%FY 2022: -57.1%FY 2023: 23.5%FY 2024: 21.7%
FY 2019 FY 2024
Free Cash Flow 14.7%
FY 2019: 0.0%FY 2020: 39.1%FY 2021: -306.0%FY 2022: -47.8%FY 2023: 10.4%FY 2024: 14.7%
FY 2019 FY 2024

Financial Health

Current Ratio 2.6×
FY 2019: 1.9×FY 2020: 1.7×FY 2021: 5.1×FY 2022: 3.0×FY 2023: 3.4×FY 2024: 2.6×
FY 2019 5y median 3.0× FY 2024
Quick Ratio 1.8×
FY 2019: 1.7×FY 2020: 1.4×FY 2021: 4.8×FY 2022: 2.6×FY 2023: 2.9×FY 2024: 1.8×
FY 2019 5y median 2.6× FY 2024
Debt / Equity 11.1×
FY 2019: -0.8×FY 2020: 1.9×FY 2021: 0.3×FY 2022: 1.3×FY 2023: 1.6×FY 2024: 11.1×
FY 2019 5y median 1.6× FY 2024
Net Debt / EBITDA -1.9×
FY 2019: -1.4×FY 2020: -1.8×FY 2021: 2.3×FY 2022: -0.0×FY 2023: -0.1×FY 2024: -1.9×
FY 2019 5y median -0.1× FY 2024
Interest Coverage -4.5×
FY 2019: -7.2×FY 2020: -4.2×FY 2021: -12.0×FY 2022: -14.5×FY 2023: -6.6×FY 2024: -4.5×
FY 2019 5y median -6.6× FY 2024

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.3%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -3.3%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31